v3.26.1
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (2,090,155) $ (1,877,301)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:    
Depreciation 16,700 6,694
Amortization 9,165 10,103
Amortization of Capitalized Share-Based Payments 44,578 44,118
Share-Based Compensation under Equity Incentive Plan 79,524 142,645
Change in Fair Value of Derivative Liabilities 4,567 (5,105)
Change in Inventory Reserve (251,677)
Changes in Operating Assets and Liabilities:    
Accounts Receivable 173,808 (1,495)
Prepaid and Other Assets (742,717) 131,689
Inventory (2,002) (330,474)
Accounts Payable and Accrued Liabilities 11,735 261,905
Accrued Interest, net 4,915 19,855
Net Cash Used in Operating Activities (2,741,559) (1,597,366)
CASH FLOWS FROM INVESTING ACTIVITIES    
Capitalization of Patents (2,804)
Purchases of Fixed Assets (30,000) (2,678)
Acquisition of Intangibles (11,440)
Maturities of Short-Term Investments 1,235,000 1,708,000
Net Cash Provided by Investing Activities 1,193,560 1,702,518
CASH FLOWS FROM FINANCING ACTIVITIES    
Net Proceeds from ATM Offering 3,369,752
Net Proceeds from January 2025 Offering 804,346
Net Proceeds from February 2025 Offering 908,627
Shares Withheld for Net Share Settlement of Performance Bonuses (18,000)
Proceeds from Exercise of Pre-Funded Warrants 1,926
Net Cash Provided by Financing Activities 3,369,752 1,696,899
Effect of Exchange Rate Changes on Cash 5,942 (9,904)
Change in Cash and Cash Equivalents 1,827,695 1,792,147
Cash and Cash Equivalents—Beginning of Period 1,510,065 1,659,353
Cash and Cash Equivalents—End of Period 3,337,760 3,451,500
NONCASH INVESTING/FINANCING ACTIVITIES    
Purchases of Fixed Assets included in Accounts Payable 10,000
Capitalized Patent Costs included in Accounts Payable 16,576
Gross Shares Issued for Annual Performance Bonuses $ 121,544